Health
Regeneron COVID-19 drug trial halted in sickest patients – Fox Business
Suspension is due to safety concern; testing continues in patients with less serious cases
Regeneron Pharmaceuticals Inc. suspended testing of its Covid-19 antibody drug in the sickest hospitalized patients because of a safety concern, the latest setback for antibody-drug trials in patients with the most advanced disease.
Regeneron said Friday it is pausing enrollment of hospitalized Covid-19 patients receiving mechanical ventilation or high-flow oxygen, after an independent monitoring committee observed a potential safety signal and an unfavorable risk/benefit profile at this time.
The…
-
Noosa News19 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General19 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News18 hours agoMurray Watt claims Queensland will follow Sussan Ley and ditch net zero by 2050
-
General16 hours agoRussian barrage kills 25 in Ukraine city as Zelenskyy holds talks with Turkish leader